These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18922203)

  • 1. Neuroprogression: pathways to progressive brain changes in bipolar disorder.
    Berk M
    Int J Neuropsychopharmacol; 2009 May; 12(4):441-5. PubMed ID: 18922203
    [No Abstract]   [Full Text] [Related]  

  • 2. From neuroprogression to neuroprotection: implications for clinical care.
    Berk M; Conus P; Kapczinski F; Andreazza AC; Yücel M; Wood SJ; Pantelis C; Malhi GS; Dodd S; Bechdolf A; Amminger GP; Hickie IB; McGorry PD
    Med J Aust; 2010 Aug; 193(S4):S36-40. PubMed ID: 20712560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: Mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway.
    Valvassori SS; Resende WR; Lopes-Borges J; Mariot E; Dal-Pont GC; Vitto MF; Luz G; de Souza CT; Quevedo J
    J Psychiatr Res; 2015 Jun; 65():63-70. PubMed ID: 25959616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
    Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
    Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder: a preliminary observation.
    Kato T; Fujii K; Kamiya A; Kato N
    Psychiatry Clin Neurosci; 2000 Feb; 54(1):117-20. PubMed ID: 15558889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models of bipolar disease and their clinical implications.
    Kupfer DJ
    Biol Psychiatry; 2000 Sep; 48(6):428-9. PubMed ID: 11018213
    [No Abstract]   [Full Text] [Related]  

  • 8. The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder.
    Bauer IE; Soares JC; Selek S; Meyer TD
    Mod Trends Pharmacopsychiatry; 2017; 31():10-26. PubMed ID: 28738324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.
    Wang JF
    Can J Psychiatry; 2007 Dec; 52(12):753-62. PubMed ID: 18186175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats.
    Gazal M; Valente MR; Acosta BA; Kaufmann FN; Braganhol E; Lencina CL; Stefanello FM; Ghisleni G; Kaster MP
    Eur J Pharmacol; 2014 Feb; 724():132-9. PubMed ID: 24384407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar disorder, homocysteine and white matter hyperintensities.
    dos Santos A; da Silva JA; Almeida J; Corrêa BB; Gago J; Xavier M
    Bipolar Disord; 2008 Sep; 10(6):748-9. PubMed ID: 18837871
    [No Abstract]   [Full Text] [Related]  

  • 12. Putative neuroprotective agents in neuropsychiatric disorders.
    Dodd S; Maes M; Anderson G; Dean OM; Moylan S; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():135-45. PubMed ID: 23178231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC; Eisch AJ
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
    Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
    Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What clinicians need to know about neuroprotective issues in bipolar disorder.
    Maletic V
    J Clin Psychiatry; 2007 Dec; 68(12):e29. PubMed ID: 18162009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.
    Cuperfain AB; Kennedy JL; Gonçalves VF
    Neurosci Biobehav Rev; 2020 Apr; 111():125-134. PubMed ID: 31978440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neocortical levels of lithium are increased in bipolar disorder.
    Friedlich AL
    Mol Psychiatry; 2012 Jan; 17(1):3-4. PubMed ID: 21808254
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of lithium and anticonvulsants on brain structure in bipolar disorder.
    Germaná C; Kempton MJ; Sarnicola A; Christodoulou T; Haldane M; Hadjulis M; Girardi P; Tatarelli R; Frangou S
    Acta Psychiatr Scand; 2010 Dec; 122(6):481-7. PubMed ID: 20560901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
    Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
    Behav Brain Res; 2014 Sep; 271():316-24. PubMed ID: 24959861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder.
    Frey BN; Dias RS
    Bipolar Disord; 2014 Feb; 16(1):48-57. PubMed ID: 24206266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.